The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab (Benlysta®) treatment for children ages five years and older with active lup ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

JSW MG Motor India has introduced a new variant of the Windsor EV, named the Exclusive Pro. This version is priced at Rs 17.24 lakh (ex-showroom). However, with the battery-as-a-service (BaaS ...

Whoop has announced two new devices — the Whoop 5.0 and the Whoop MG (MG stands for medical grade), which are available to purchase from today. The differences between the two wearable devices ...

The FDA application is based on results from OASIS 4, a 64-week phase 3 randomized, controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

Novo Nordisk hopes to expand Wegovy ® label by becoming the first GLP-1 treatment for obesity in a pill; The FDA filing is based on the results of the phase 3 OASIS 4 trial that evaluated oral ...

The FDA application is based on results from OASIS 4, a 64-week phase 3 randomized, controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 ...

The FDA application is based on results from OASIS 4, a 64-week phase 3 randomized, controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 ...